A Simple Method for Co-Segregation Analysis to Evaluate the Pathogenicity of Unclassified Variants; BRCA1 and BRCA2 as an Example

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-9-211
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Brca1/Brca2

2019English

Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay

Frontiers in Oncology
Cancer ResearchOncology
2018English

A Review of a Multifactorial Probability-Based Model for Classification of BRCA1 and BRCA2 Variants of Uncertain Significance (VUS)

Human Mutation
Genetics
2011English

Prediction of the Functional Impact of Missense Variants in BRCA1 and BRCA2 With BRCA-ML

2019English

Founder BRCA1/BRCA2/PALB2 Pathogenic Variants in French-Canadian Breast Cancer Cases and Controls

Scientific Reports
Multidisciplinary
2020English

Analysis of the Pathogenic Variants of BRCA1 and BRCA2 Using Next-Generation Sequencing in Women With Familial Breast Cancer: A Case–control Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Splicing and Multifactorial Analysis of Intronic BRCA1 and BRCA2 Sequence Variants Identifies Clinically Significant Splicing Aberrations Up to 12 Nucleotides From the Intron/Exon Boundary

Human Mutation
Genetics
2011English

Lessons Learned From BRCA1 and BRCA2

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy